TRAMLINES Ventures is a fund & accelerator focused on B2B startups in Deep Tech, AI, Fintech, and Enterprise Tech. It targets domain experts with at least 10 years of industry experience and takes them through a 24-month Pre-Seed and Seed programme.
 
As an Investor Relations Lead, I'm here to ensure the success of our Portco's in their fundraising efforts.

Eva Dobrzanska

The IPO market is likely to gain momentum this year, and that's a great signal for early-stage startups. The exits trigger payouts to LPs, who then are likely to commit to new funds (think VC, Angel syndicates, cVCs..) We've got 7 likely mega-IPOs on the horizon:

1. OpenAI (likely at $1T valuation)
2. SpaceX
3. Stripe
4. Anthropic
5. Databricks (est. valuation $43B)
6. Canva (valued at $42B from its most recent funding round)
7. Anduril (defense tech, raised $6.3B to date)

Another plus?

Post-IPO, employees with company shares convert their equity into liquid cash.

-> a lot of them end up angel investing in new ventures... and typically have a higher risk tolerance than traditional wealth managers. 

They are more likely to fund "crazy" early-stage ideas that institutions might skip.

#capitalraising #vcfunding #startupadvice

NEXT STOP: TRAMLINES 🚀
Excited to say I’m joining the team at Tramlines Ventures! We back domain expert founders across AI, Fintech, DeepTech & Enterprise Tech, investing at Pre Seed/ Seed and taking them through a bespoke support program extending the right commercial & investor networks around them.

The right access and advice at the earliest stages can truly make or break the business. And at Tramlines, we start from a simple assumption:

Building *durable* businesses requires strong tech applied with deep domain understanding. 

We look closely at the tech, the architecture, the data, and the full enterprise readiness.

With 7 investments to date (and 1 exit), my role will drive more of our portfolio to successful outcomes across their various stages, ranging from Pre Seed to Series A (and some reaching profitability already..)

Alas… 

💸 to the INVESTORS in my network: we should catch up. 

🛠️ to the FOUNDERS in my network: we’re actively investing. Leave a comment with a 1-sentence description of what you’re building + tag another Founder in your network. 

Our team will be actively screening all Comments throughout this week and reaching out directly to those who could be a fit. 

#newjob #vc #startupfunding #venturecapital

Albert Azis-Clauson 🦚, Ashleigh Gardner, Daniel Lanyon thank you to You and the rest of the team for this opportunity - super excited. Andrea Madaschi, Craig Donaldson, David Arden, Josie Flight, Graham McClelland, Erica Young, Rosalie Oakman, Ria Chopra, Theo Innis

Oxford SimCell Ltd

Oxford SimCell Ltd is a spin-out company from the University of Oxford, developing SimCell, a non-replicating bacterial cell platform for various healthcare applications. We currently focus on bacterial vaccine development. Other SimCell applications are also explored, including infectious diseases and cancers.

• Direct, manage, and coordinate internal operations in alignment with the policies, goals, and objectives set by the CEO and the Board of Directors.
• Participate in fundraising efforts and the development of business plans.
• Oversee the establishment and management of the lab, finance, human resources, and quality management systems.
• Build and maintain relationships with suppliers, vendors, consultants, partners, and clients.
• Manage public grant projects~£2M to ensure timely achievement of milestones.

Oxsed

• Delivering on and leading new product development of in vitro diagnostic medical devices, including clinical trials
• Participating in the establishment of ISO 13485 and ensuring that all product development plans are consistent with professional standards and regulatory requirements (2 products with CE Marking)
• Performance management of 15 Scientists, Engineers, and Laboratory Technicians and accountable for the effective performance of the R&D Department
• Engaging in ongoing market research related to market trends as well as current and prospective market drivers
• Participating in setting up and maintaining ISO 15189 for operating analytics/medical testing laboratories to a high standard
• Proactively identifying and managing project risks and issues and coordinating with the relevant internal and external stakeholders

Head of R&D

• Advising on new product development for in vitro diagnostic medical devices (2 products with CE Marking)
• Communicating with the manufacturer, advising on process R&D and scale-up (from 200 to 10K kits/day)
• Leading collaborative clinical trials

Consultant

University of Oxford

Project manager of Oxford-JITRI Institute of Materials and Processes for Advanced and Critical Technologies (IMPACT Institute), University of Oxford
• Facilitating UK-China collaborations across academia and industry
• Managing JITRI R&D grants and research calls (£900K)
• Organising international conferences and collaboration meetings (2 international conferences in the UK and China)

Project Manager

Tissue Engineering and Bioprocessing Group with Prof Zhanfeng Cui & Prof Hua (Cathy) Ye
• Developing a rapid testing technology for COVID-19 (featured on CNN and BBC; spun out into a social enterprise, Oxsed Ltd.)
• Developing structured hydrogels for neural tissue engineering applications
• Developing a spectroscopic platform to monitor neural differentiation of human induced pluripotent stem cell (hiPS) for disease modelling and drug screening applications
• Biomedical Engineering Representative, Oxford Solid Mechanics Workshop (2018 - 2020)
• Researcher Committee, Department of Engineering

Postdoctoral Research Assistant in Biomaterials for Tissue Regeneration

Working with OXWASH (an award-winning, eco-friendly laundry & dry cleaning services) to analyse market segment recovery and to make informed recommendations on the OXWASH market focus post COVID-19.
• Collecting and reviewing financial and demographic data, conducting company and industry research
• Performing market analysis for the market size and trends and the competitor landscape
• Writing a recommendation report and giving a client presentation

TOSCA Consultant - Oxford Strategy Challenge

Imperial College London

Teaching, lab demonstration, and invigilation

Graduate Teaching Assistant

National Science Council

• Translating 12 scientific articles from English into Chinese to enhance public engagement in
science (7 articles were selected as Finalists)

Scientific translator

COO at Oxford SimCell Ltd

A highly motivated, solution orientated, commercially focused professional offering a valuable combination of leadership, analytical and interpersonal skills. A proven track record of leading scientific research in in vitro diagnostics, regenerative medicine, and bioengineering. With additional expertise across all areas of product development, data visualisation and analysis, global public health improvement research/initiatives, stakeholder engagement, reporting, quality management systems, regulatory submission, coaching and influencing. Confident, diligent, gritty and thoroughly dedicated in all pursuits.

taplio

The Battle

Eva Dobrzanska

Chia-Chen (Jane) Hsu

Followers

Posts

Engagements

Likes

Performance ScoreEva Dobrzanska's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

Eva Dobrzanska

Chia-Chen (Jane) Hsu

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Eva Dobrzanska's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreEva Dobrzanska's LinkedIn Performance